Certificate Of Need

AAA

DEFINITION of 'Certificate Of Need'

An endorsement required by numerous states before the construction of a new health care facility will be approved. The central idea of Certificate of Need legislation is the assertion that overbuilding and redundancy in health care facilities leads to higher health care costs. Thus to ensure that a new hospital or nursing home is necessary, a state authority conducts a study to determine whether the local demand is sufficient to allow for the construction of a new facility.

INVESTOPEDIA EXPLAINS 'Certificate Of Need'

Certificate of Need programs have been controversial since their introduction in 1964. Advocates of the programs believe that health care is not a regular economic good and cannot be left to free market. Opponents challenge the assertion that unrestrained construction would lead to higher health care prices. To the contrary, opponents argue that preventing new construction acts as a barrier to competition and keeps prices high.



RELATED TERMS
  1. Equilibrium

    The state in which market supply and demand balance each other ...
  2. Healthcare Sector

    A category of stocks relating to medical and healthcare goods ...
  3. Market Failure

    An economic term that encompasses a situation where, in any given ...
  4. Normal Good

    An economic term used to describe the quantity demanded for a ...
  5. Market Distortion

    An economic scenario that occurs when there is an intervention ...
  6. Credentialing Liability

    Liabilities that a hospital or medical facility faces for the ...
RELATED FAQS
  1. Why should an investor include an allocation to the drugs sector in their portfolio?

    Both conservative and high-risk investors can find things to like in the health care sector, particularly in the drugs subsector. ... Read Full Answer >>
  2. What does it mean when a drug is in clinical trials and how long does it take to ...

    Clinical trials are research studies designed to determine the safety and effectiveness of new drugs in humans. All products ... Read Full Answer >>
  3. What companies are positioned to grow from the popularity of ETFs?

    Some of the companies best-positioned to benefit from the explosion in the popularity of exchange-traded funds (ETFs) are ... Read Full Answer >>
  4. What is revenue cycle management?

    Revenue cycle management is a big-picture sales, collection and payment processing technique, popular among healthcare providers. ... Read Full Answer >>
  5. What is happening during a risk repricing?

    During a strong bull market, the market's overall sense of optimism can often lead to poor estimates about the level of risk ... Read Full Answer >>
Related Articles
  1. Home & Auto

    Fighting The High Costs Of Healthcare

    If your employer is cutting medical benefits, a health savings account may be right for you.
  2. Fundamental Analysis

    Evaluating Pharmaceutical Companies

    Learn how to find a healthy pharmaceutical investment in a market full of weak drugs.
  3. Insurance

    What Does Medicare Cover?

    Don't assume you're insured. Find out what you can expect from this healthcare program.
  4. Insurance

    Find Secure And Affordable Post-Work Health Insurance

    Learn how you can avoid financial catastrophe - without Medicare.
  5. Retirement

    Health-y Savings Accounts

    HSAs can provide a new way to save for retirement and medical expenses.
  6. Mutual Funds & ETFs

    6 ETFs to Fight Your Recession Jitters

    Are you worried about a recession? If so, consider these 6 ETFs.
  7. Stock Analysis

    Healthcare Stocks: A Prescription for More Gains?

    There could be even more room for gains in healthcare sector stocks, as many of the bullish trends remain in place.
  8. Stock Analysis

    Could This Drug Make Isis Pharmaceuticals Soar?

    Warfarin has been doctors' go-to anticoagulant for decades, but recently launched next-generation anticoagulants are increasingly winning market share.
  9. Stock Analysis

    What’s The Smartest Way To Play Tobacco Stocks?

    While the United States economy continues to grow, the U.S. tobacco industry keeps shrinking.
  10. Stock Analysis

    Did Orexigen Make A Big Mistake?

    Developing drugs isn't cheap. Drugmakers spend $1.4 billion in direct costs to bring a typical drug through research trials to commercialization.

You May Also Like

Hot Definitions
  1. Fiduciary

    1. A person legally appointed and authorized to hold assets in trust for another person. The fiduciary manages the assets ...
  2. Expected Return

    The amount one would anticipate receiving on an investment that has various known or expected rates of return. For example, ...
  3. Carrying Value

    An accounting measure of value, where the value of an asset or a company is based on the figures in the company's balance ...
  4. Capital Account

    A national account that shows the net change in asset ownership for a nation. The capital account is the net result of public ...
  5. Brand Equity

    The value premium that a company realizes from a product with a recognizable name as compared to its generic equivalent. ...
Trading Center